To investigate the role of allosteric SMURF1 inhibition on BMP signaling in disease-relevant cells, pulmonary artery smooth muscle cells (PASMCs) from patients with idiopathic and heritable PAH were treated with BMP4 and cultured in the presence of a SMURF1 inhibitor or vehicle. Here, BMP4 is linked to pulmonary arterial hypertension.